Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03810313 |
|---|---|
| Brief Title: | Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (RAVEN) |
| First Submitted : | January 17, 2019 |
| First Submitted that Met QC Criteria : | January 17, 2019 |
| First Posted : | January 18, 2019 |
| Last Update Submitted that Met QC Criteria : | March 12, 2021 |
| Last Update Posted : | March 16, 2021 |